Corbus Pharmaceuticals Holding (CRBP)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.07B
EV to revenue ratio (TTM)
4,531.61
EV to ebitda
0.17
Financial Performance
Revenue (TTM)
$0B
Gross profit (TTM)
-$0.09B
EBITDA
-$0.11B
Profitability
Operating margin (TTM)
<0.01%
Profit margin
<0.01%
Return on assets (TTM)
-53.00%
Return on equity (TTM)
-95.60%
Per Share Metrics
Revenue per share (TTM)
$0
EPS
-$6.11
Diluted EPS (TTM)
-$6.11
Book value
$5.48
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
169.88
Price to book ratio (TTM)
0.58
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
9
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.79